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4   Ballot Measure Summary
ARGUMENTS ARGUMENTS
FOR ADDITIONAL INFORMATION FOR ADDITIONAL INFORMATION
WHAT YOUR VOTE MEANS WHAT YOUR VOTE MEANS
SUMMARY SUMMARY
PROPOSITION Redistricting. 
Initiative Constitutional Amendment.
YES
A YES vote on this measure 
means: Boundaries for 
political districts would be 
drawn by retired judges 
and approved by voters 
at statewide elections. A 
redistricting plan would be 
developed for use following 
the measure’s approval and 
then following each future 
federal census.
NO
A NO vote on this measure 
means: Boundaries for 
political districts would 
continue to be drawn 
by the Legislature and 
approved by the Governor. 
A redistricting plan would 
be developed following 
each future federal census.
PRO
PROPOSITION 77 
MAKES POLITICIANS 
ACCOUNTABLE TO THE 
PEOPLE. Yes on Prop. 77 
guarantees fair, competitive 
elections by ensuring voters 
have the fi nal say on voting 
districts—not politicians. 
Prop. 77 reduces special 
interest infl uence and holds
politicians accountable to
their constituents. Fair
Districts, Real Competition
—Yes on 77.
CON
Sponsors want you to believe 
Prop. 77 makes government 
better. Don’t be fooled! Read 
the fi ne print: Voters lose their 
right to reject redistricting 
before it becomes effective; 
politicians pick judges to draw 
districts for them; it costs 
taxpayers millions; and is 
cemented into our Constitution. 
Vote No on 77!
FOR
Edward J. Costa
People’s Advocate
3407 Arden Way
Sacramento, CA 95825
(916) 482-6175
emily@peoplesadvocate.org
AGAINST
Californians for Fair 
Representation—No on 77
1127 11th Street, Suite 950
Sacramento, CA 95814
(916) 448-7724
www.noonproposition77.com
77
Amends state Constitution’s process for redistricting 
California’s Senate, Assembly, Congressional and Board 
of Equalization districts. Requires three-member panel of 
retired judges selected by legislative leaders. Fiscal Impact: 
One-time state redistricting costs totaling no more than 
$1.5 million and county costs in the range of $1 million. 
Potential reduction in future costs, but net impact would 
depend on decisions by voters.
PROPOSITION Discounts on Prescription Drugs. 
Initiative Statute.
YES
A YES vote on this measure 
means: A new state drug 
discount program would be 
created to reduce the costs 
that certain residents of the 
state, including persons in 
families with an income at 
or below 300 percent of the 
federal poverty level, would 
pay for prescription drugs 
purchased at pharmacies.
NO
A NO vote on this measure 
means: The state would not 
expand its drug discount 
program beyond an existing
state program that assists 
elderly and disabled persons
on Medicare.
PRO
Proposition 78 provides that 
millions of seniors and low 
income, uninsured Californians 
can buy prescription drugs at 
discounts of 40%. Adapted 
from a successful program 
operating in Ohio, Prop. 78 
can take effect immediately 
without a big government 
bureaucracy. Seniors, 
taxpayers, nurses, doctors, 
and patient advocates say 
Yes on Proposition 78. 
www.calrxnow.org 
CON
SPONSORED BY THE 
PRESCRIPTION DRUG 
COMPANIES, Prop. 78 
is a SMOKESCREEN to 
stop Prop. 79, a real, 
enforceable plan backed by 
consumer groups. Under 
the “voluntary” Prop. 78, 
drug companies don’t have 
to provide a single discount, 
and the plan can END AT 
ANY TIME. VOTE NO on 
Prop. 78. 
FOR
Californians for 
Affordable Prescriptions
1415 L Street, Suite 1250
Sacramento, CA 95814
info@calrxnow.org
www.calrxnow.org
AGAINST
Anthony Wright
Health Access California
414 13th Street, Suite 450
Oakland, CA 94612
(510) 873-8787
awright@health-access.org
www.VoteNoOnProp78.com
78
Establishes discount prescription drug program
for certain low- and moderate-income Californians. 
Authorizes Department of Health Services to contract 
with participating pharmacies for discounts and with 
participating drug manufacturers for rebates. Fiscal 
Impact: State costs for administration and outreach in the 
millions to low tens of millions of dollars annually. State 
costs for advance funding for rebates. Unknown potentially 
signifi cant savings for state and county health programs.
DISCOUNTS ON PRESCRIPTION DRUGS.
INITIATIVE STATUTE.78
PROPOSITION
Offi cial Title and Summary
36   Title and Summary/Analysis
Prepared by the Attorney General 
D  P D. I S.
• Establishes discount prescription drug program, overseen by California Department of Health Services.
• Enables certain low- and moderate-income California residents to purchase prescription drugs at 
reduced prices.
• Authorizes Department: to contract with participating pharmacies to sell prescription drugs at agreed-upon 
discounts negotiated in advance; to negotiate rebate agreements with participating drug manufacturers. 
• Imposes $15 annual application fee.
• Creates state fund for deposit of drug manufacturers’ rebate payments.
• Requires Department’s prompt determination of residents’ eligibility, based on listed qualifi cations. 
• Permits outreach programs to increase public awareness.
• Allows program to be terminated under specifi ed conditions.
Summary of Legislative Analyst’s Estimate of Net State and Local 
Government Fiscal Impact:
• One-time and ongoing state costs, potentially in the millions to low tens of millions of dollars annually, for 
administration and outreach activities for a new drug discount program. A signifi cant share of these costs 
would probably be borne by the state General Fund.
• State costs, potentially in the low tens of millions of dollars, to cover the funding gap between when drug 
rebates are collected by the state and when the state pays funds to pharmacies for drug discounts provided 
to consumers. Any such costs not covered through advance rebate payments from drug makers would be 
borne by the state General Fund.
• Unknown potentially signifi cant savings for state and county health programs due to the availability of drug 
discounts.
• Potential unknown effects on state revenues and expenditures from changes in prices and quantities of 
drugs sold in California.
ANALYSIS BY THE LEGISLATIVE ANALYST
Background
Prescription Drug Coverage. Currently, several state 
and federal programs provide prescription drug 
coverage to eligible individuals. The state’s Medi-Cal 
Program, which is administered by the Department 
of Health Services (DHS), provides prescription 
drugs for low-income children and adults. The state’s 
Managed Risk Medical Insurance Board administers 
the Healthy Families Program, which provides 
prescription drugs for children in low-income and 
moderate-income families who do not qualify for 
Medi-Cal.
Beginning January 2006, the federal government 
will provide prescription drug coverage to persons 
enrolled in Medicare, a federal health program for 
elderly and disabled persons. (This would include 
some persons enrolled in Medi-Cal who are also 
enrolled in Medicare.) Various other programs 
funded with state or federal funds also provide 
assistance to help pay part or all of the cost of drugs 
for specifi ed individuals. 
In addition, many Californians receive coverage 
for prescription drugs through private insurance 
that is purchased by individuals or provided by their 
employer or the employer of a member of their 
family.
Drug Discount Programs. California, a number 
of other states, and private associations and drug 
makers have established drug discount programs. 
These programs help certain consumers, including 
individuals who are not eligible for state and 
federal programs that provide drug coverage, 
purchase prescription drugs at reduced prices. 
Current California law, for example, requires retail 
pharmacies to sell prescription drugs at a discount 
to elderly and disabled persons enrolled in Medicare 
as a condition of a pharmacy’s participation in the 
Medi-Cal Program.
Proposal
This proposition creates a new state drug discount 
program to reduce the costs that certain residents of 
the state would pay for prescription drugs purchased 
at pharmacies. The major components of the measure 
are outlined below. 
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Discount Card Program. Under the new drug 
discount program, eligible persons could obtain a 
card that would qualify them for discounts on their 
drug purchases at pharmacies. The program would 
be open to California residents in families with an 
income at or below 300 percent of the federal poverty 
level—up to almost $29,000 a year for an individual 
or about $58,000 for a family of four. Persons 
enrolled in Medicare could obtain discount cards 
for drugs not covered by Medicare. Persons could 
not participate in the new drug discount program if 
they receive their drug coverage from private health 
insurance, from the Medi-Cal or Healthy Families 
Programs, or from other public programs supported 
with state or federal funding. Persons generally could 
not obtain a drug discount card for at least three 
months after leaving these private or public sources 
of drug coverage.
The new drug discount program would be 
administered by DHS, which could contract with 
a private vendor for assistance. Participants would 
enroll in the program by paying a $15 fee, and would 
pay an annual renewal fee of the same amount. 
Eligible persons could enroll or reenroll in the 
program at any pharmacy, doctor’s offi ce, or clinic, 
which chose to participate in the drug discount 
program. Applications and renewals could also be 
handled through an Internet Web site or through 
a telephone call center. The DHS would review 
applications and mail the drug discount cards to 
eligible persons, usually within four days.
The state would seek two types of discounts in order 
to obtain lower prices for persons with the new drug 
discount cards. First, pharmacies that voluntarily 
chose to participate in the program would agree to 
sell prescription drugs to cardholders at an agreed-upon 
discount negotiated in advance with the state. In 
addition, pharmacies would further discount the 
price to refl ect any rebates the state negotiated with 
drug makers. (The pharmacies would subsequently 
be reimbursed for this second type of discount with 
rebates collected by the state from drug makers.)
The DHS could end the drug discount program 
if it found there were insuffi cient discounts to make 
the program work, if too few persons enrolled in the 
program, or if DHS could not fi nd a vendor to help 
run the program.
Private Drug Discount Programs. The measure directs 
DHS to implement agreements with drug discount 
programs operated by drug makers and other private 
groups so that the discount cards would automatically 
provide consumers with access to the best discount 
available to them for a particular drug purchase.
Outreach Efforts. The measure directs DHS to 
conduct an outreach program to inform state 
residents about the new drug discount program. 
Related Provisions in Proposition 79. Proposition 79 
on this ballot also establishes a new state drug discount 
program. The key differences between Proposition 78 
and Proposition 79 are shown in Figure 1.
The State Constitution provides that if a particular 
provision of a proposition that has been approved 
by the voters is in confl ict with a particular provision 
of another proposition approved by the voters, 
only the provision in the measure with the higher 
number of yes votes would take effect. Proposition 78 
specifi es that its provisions would go into effect in 
their entirety, and that none of the provisions of a 
competing measure such as Proposition 79 would take 
effect, if Proposition 78 received the higher number 
of yes votes.
Fiscal Effects
This measure could have a number of fi scal effects 
on state and local government. We discuss several major 
factors below that could result in costs or savings.
State Costs for Administration and Outreach Activities. 
The DHS would incur signifi cant startup costs, as 
well as ongoing costs, for administrative and outreach 
activities to implement the new drug discount 
program created by this proposition. 
This would include administrative costs to:
• Establish the new program, including any new 
information technology systems that would be 
needed for its operation. 
• Operate the Internet Web site and the call center 
to receive applications for drug discount cards.
• Process applications and renewals of drug discount 
cards.
• Negotiate and collect rebates from drug 
manufacturers and make advance rebate payments 
to pharmacies.
• Coordinate the state’s drug discount program with 
other private drug discount programs.
The state could also incur additional costs for the 
proposed outreach activities, potentially including 
costs for radio or television advertising, written 
materials, and other promotional efforts to make 
consumers aware of the drug discount program.
In the aggregate, these administrative and outreach 
costs would probably range from the millions to 
low tens of millions of dollars annually. The exact 
fi scal effect would depend primarily on the extent of 
outreach efforts and the number of consumers who 
chose to participate in the drug discount program.
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FIGURE 1
KEY DIFFERENCES BETWEEN PROPOSITIONS 78 AND 79
Proposition 78 Proposition 79
General eligibility 
requirements
• California residents in families with an 
income at or below 300 percent of the 
federal poverty level. (About $29,000 
annually for an individual and $58,000 
for a family of four.)
• No such provision.
• California residents in families with an 
income at or below 400 percent of the 
federal poverty level. (About $38,000 
annually for an individual and $77,000 
for a family of four.) 
• Also, persons in families with medical 
expenses at or above 5 percent of their 
family’s income. 
Persons excluded 
from coverage
• Persons with outpatient prescription 
drug coverage through Medi-Cal, 
Healthy Families, a third-party payer, or 
a health plan or drug discount program 
supported with state or federal funds 
(except Medicare benefi ciaries).
• Certain persons with drug coverage, 
during the three-month period prior 
to the month the person applied for a 
drug discount card.
• Persons with outpatient prescription 
drug coverage through Medi-Cal or 
Healthy Families (except Medicare 
benefi ciaries).
• No such provision.
Application and 
renewal fee
• $15 per year. • $10 per year.
Method of obtaining 
rebates from drug 
makers
• Negotiated with drug makers.
• No such provision.
• Negotiated with drug makers. 
• Subject to federal approval, links new 
drug discount program to Medi-Cal for 
the purpose of obtaining rebates on 
drugs.
Assistance to 
business and labor 
organizations
• No such provision. • Establishes drug discount program 
to assist certain business and labor 
entities.
Prescription Drug 
Advisory Board
• No such provision. • Creates new nine-member panel to 
review the access to and pricing of 
drugs.
Lawsuits over drug 
profi teering law
• No such provision. • Changes state law to make it a civil 
violation for a drug maker to engage in 
profi teering from the sale of drugs. 
ANALYSIS BY THE LEGISLATIVE ANALYST (CONTINUED)
Discounts on Prescription Drugs.
Initiative Statute.78
PROPOSITION
For text of Proposition 78 see page 66. Analysis   39
These costs could be partly offset by (1) any funds 
available for this purpose from a new special fund 
created by this measure, (2) any private donations 
received for this purpose, and (3) a portion of the 
enrollment fees collected for the program. The 
amount of donations that the state would receive on 
an ongoing basis for outreach activities is unknown. 
The amount of available special funds or the fee 
revenues that would be collected by the state is also 
unknown. In view of the above, it appears likely that a 
signifi cant share of the cost of this program would be 
borne by the General Fund.
Costs for “Float.” This measure requires the state to 
reimburse pharmacies for part of the amount that 
they discounted their drugs. This reimbursement 
refl ects discounts for which the state receives rebates 
from drug makers. 
The reimbursement to pharmacies must be made 
within two weeks after their claims are fi led with 
the state. However, drug makers are required by 
the measure to pay rebates to the state on at least a 
quarterly basis. This means that the state could, in 
many cases, pay out rebates to pharmacies before 
it actually collects the rebate funds from drug 
makers. Moreover, any disputes that arise over the 
actual amounts owed for rebates could further slow 
payments of rebate funds by drug makers to the state. 
This recurring gap in funding between when rebate 
money is collected by the state and when the state has 
to pay pharmacies is commonly referred to as fl oat. 
The cost of the fl oat is unknown, but could amount 
to the low tens of millions of dollars, depending 
on the level of participation in the program. Float 
costs would occur mainly in the early years of 
implementing this new program. After the program 
has been fully implemented, rebate funds collected 
from drug makers should be largely suffi cient to 
reimburse pharmacies.
This measure permits the state to enter into 
agreements with drug makers to collect some rebate 
funds in advance. The amount of funding that the 
state would receive through such advance payments 
is unknown. Any fl oat costs that exceeded these 
advance rebate payments would be borne by the state 
General Fund.
Potential Savings for State and County Health 
Programs. The drug discount program established 
under this proposition could reduce costs to the state 
and counties for health programs. 
Absent the discounts available under such a drug 
discount program, some lower-income individuals 
who lack drug coverage might forego the purchase 
of their prescribed drugs. Such individuals might 
eventually require hospitalization as a result of their 
untreated medical conditions, thereby adding to 
Medi-Cal Program costs. Other individuals might 
“spend down” their fi nancial assets on expensive drug 
purchases absent such discounts and become eligible 
for Medi-Cal. The exact amount of savings to the 
Medi-Cal Program from a drug discount program 
is unknown, but could be signifi cant if the program 
enrolled a large number of consumers.
Similarly, the availability of a drug discount 
program could reduce costs for other state health 
programs. It could also do so for county indigent care 
by decreasing out-of-pocket drug expenses for 
low-income persons who require medications, thereby 
making them less likely to rely on county hospitals or 
clinics for assistance. The extent of these potential 
savings is unknown.
Other Fiscal Effects. This measure would affect 
both the prices and quantities of prescription drugs 
sold in California. In turn, this could affect taxable 
profi ts of drug makers and businesses that provide 
health care for their employees, as well as consumers’ 
disposable income. These changes could affect state 
revenues. Changes in the prices and quantities of 
drugs sold could affect state expenditures as well. 
The net impact of these factors on state revenues and 
expenditures is unknown.
78
PROPOSITION Discounts on Prescription Drugs.
Initiative Statute.
Argument in Favor of Proposition 78
Arguments printed on this page are the opinions of the authors and have not been checked for accuracy by any offi cial agency.40   Arguments
Proposition 78 offers Californians struggling with high 
prescription drug costs real help, right now. Prop. 78 is a 
proven program that can take effect immediately, and will 
deliver critically needed prescription drug discounts to 
millions of seniors and low income, uninsured Californians.
Known as Cal Rx, Proposition 78 offers Californians the 
best prescription drug discount program in the country. 
It is an improved version of a successful program already 
operating in Ohio that is delivering discounts averaging 
31%, saving consumers $15.31 on every covered prescription. 
Every major prescription drug manufacturer participates in 
the Ohio program.
“This program is a lifesaver. My family saves $150 a 
month on prescription drugs for my husband’s heart 
condition. For us, it’s a miracle.”
Robin Ford, Canton, Ohio
Proposition 78 is even better than the Ohio program. The 
California Department of Health Services concludes that 
the Cal Rx program enacted by Proposition 78 will result in 
discounts of over 40% to millions of eligible Californians. 
State offi cials say that Cal Rx prices will compare favorably to 
prices in Canada.
Here’s how Proposition 78 works:
• The program covers seniors and the uninsured with family 
incomes up to $58,000 annually.
• Manufacturers will provide prescription drugs to the 
Cal Rx program at the lowest commercial price they sell 
to anyone in California and pharmacists will provide 
additional discounts. According to state offi cials, the 
average discount will be at least 40% off regular retail 
prices.
• Prop. 78 also makes it easier for people to get access to 
new and existing free drug programs, meaning even more 
savings for consumers.
• Enrollment is simple. People can sign up at their local 
pharmacy.
• Prop. 78 does not require a big government bureaucracy 
to implement. The discounts go right to the patient in 
their community.
• ALL drugs are eligible for discounts under Proposition 78, 
not just those on a government determined list.
“Proposition 78 offers real hope to millions of 
Californians who currently don’t have access to 
affordable prescription medications. We want all 
Californians in need to have access to prescription 
medications and Proposition 78 will do that.”
Rick Roberts, HIV/AIDS Patient and Activist
Proposition 78 enjoys bipartisan support. It is supported 
by groups representing seniors, patients, taxpayers, and small 
businesses across the state. A Los Angeles Times news report 
found Prop. 78, “would offer one of the most extensive 
discounts in the country.” 
Proposition 78 will bring real help, right now. It can go 
into effect immediately and begin delivering deep discounts 
on prescription drugs, helping millions of seniors and low 
income, uninsured Californians. 
There are two prescription drug discount proposals on the 
ballot, but only Proposition 78 will work. Unlike the other 
proposal, Prop. 78 doesn’t require federal approval, provides 
discounts on a wider range of drugs, doesn’t depend on a 
big government bureaucracy to be implemented, and won’t 
result in costly litigation by trial lawyers. 
Please, join seniors, taxpayers, consumers, patient 
advocates, health care professionals, and small businesses, 
and VOTE YES on Proposition 78. 
KRISTINE YAHN, RN, Executive Director 
Californians for Patient Care 
CAROLYN PETERSON, RN, MS, AOCN
Chief Operating Offi cer
Community Hospice 
DORIS LUNA, RN, Certifi ed Pediatric Oncology Nurse 
UC Davis Medical Center 
 Why are Californians struggling with high drug prices? 
Because the drug companies funding Prop. 78 charge high 
prices.
If drug companies want to offer discounts voluntarily, they can do 
it today, without an initiative, without a new program.
• Prop. 78 provides smaller discounts to fewer people and 
does not allow the state to enforce the discounts. This 
approach already failed in California. 
• Prop. 79 builds on existing efforts that have saved 
taxpayers billions. It gives more middle and low income 
Californians bigger discounts that can be enforced.
PROP. 78 USES AN APPROACH THAT HAS FAILED IN 
CALIFORNIA AND ELSEWHERE
In 2001, California created the Golden Bear State 
Pharmacy which relied on drug companies to voluntarily 
lower their prices. The state shut it down because very few 
drug companies agreed to participate.
Prop. 78 uses the same failed approach.
PROP. 78: SMALLER DISCOUNTS, FEWER PEOPLE, NO 
ENFORCEMENT
Drug companies face no penalty under Prop. 78 if they fail to 
provide discounts and the industry can shut down Prop. 78 at 
any time by failing to participate. Prop. 78 does not require 
any, much less all, drugs to be discounted, and it offers 
smaller discounts to fewer people.
DON’T BE FOOLED: If Prop. 78 gets more votes than Prop. 
79, drug companies win and Californians lose.
That’s why drug companies contributed more than $50 
million to pass Prop. 78 and defeat Prop. 79. That’s why 
consumers, seniors, unions, nurses, and doctors say VOTE 
NO on 78 and YES on 79.
BARBARA A. BRENNER, Executive Director 
Breast Cancer Action
RAMÓN CASTELLBLANCH, Policy Advisor 
Senior Action Network
KATHY J. SACKMAN, RN, President 
United Nurses Association of California
Rebuttal to Argument in Favor of Proposition 78
Discounts on Prescription Drugs.
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THE DRUG LOBBY IS SPENDING HISTORIC 
AMOUNTS TO BLOCK THE REAL SOLUTION FOR FAIR 
DRUG PRICES 
Prop. 78 is a smokescreen designed and bankrolled with 
tens of millions of dollars from the prescription drug lobby 
to block Prop. 79, a real discount solution put forward by 
consumer, health, and senior groups. Under their cynical 
strategy, if both measures get a majority, the one with more votes 
becomes law. 
Newspapers report that just one contribution from 
GlaxoSmithKline for $8.5 million could be “the largest ever 
from a corporation to a California campaign.” Drug companies 
donated $50 million to Prop. 78 by mid-July, on track to run what 
could be the most expensive initiative campaign in California 
history. 
Jan Faiks, VP with PhRMA, the industry’s lobbying 
arm, told the Los Angeles Times “the industry would spend 
‘whatever it takes’ to defeat [Prop. 79].” 
PROP. 78 RELIES ON MANUFACTURERS TO 
VOLUNTEER DISCOUNTS: A PLAN PROVEN TO FAIL 
Prop. 78 relies on drug manufacturers to voluntarily lower 
their prices and does not allow the state of California to 
enforce the program. 
California tried this voluntary approach in 2001. The Golden 
Bear State Pharmacy was designed to offer seniors voluntary 
discounts on prescription medications. More than 500 
drug manufacturers were invited to participate, yet only 
14 agreed. Unable to implement it successfully, Governor 
Schwarzenegger closed the program. 
According to news reports, the drug companies said they 
didn’t participate in Golden Bear because if they did, they 
would have to give the federal government the same rebates 
they were giving California seniors. Have they really changed 
their minds four years later? Can we trust the manufacturers 
to voluntarily lower their prices now? No. 
PROP. 78’S DISCOUNTS CAN END AT ANY TIME 
The drug lobby buried a provision in Prop. 78 that allows 
them to effectively close their discount program when too 
few manufacturers voluntarily lower their prices. 
As stated in their initiative, Prop. 78 could end at any time 
if there are too few participating manufacturers, or insuffi cient 
discounts, or too few participating consumers. 
Make no mistake, this provision was included by the drug 
companies so they can end the program at any time and 
protect their profi t margins. 
FEWER PEOPLE ARE ELIGIBLE, DISCOUNTS ARE LESS 
Half as many Californians are eligible for discounts under Prop. 
78 as under Prop. 79. Prop. 78 provides no discounts to many 
uninsured Californians, those with catastrophic medical bills, 
and the chronically ill such as cancer and diabetes patients 
with inadequate drug coverage. 
The discounts offered by Prop. 78 are based on the 
“lowest commercial price” set by the drug companies. These 
discounts could be anywhere from 15 to 40 percent—
signifi cantly less than Prop. 79’s discounts. 
VOTE NO on PROP. 78, a smokescreen by the 
pharmaceutical industry to block the real solution to high 
prices. 
Instead, VOTE YES on PROP. 79 for fair prescription drug 
prices. 
NANCY J. BRASMER, President
California Alliance for Retired Americans 
RICHARD HOLOBER, Executive Director
Consumer Federation of California 
JACQUELINE JACOBBERGER, President
League of Women Voters of California 
Proposition 78 is based on a successful Ohio program 
that delivers big discounts to consumers. Every major drug 
manufacturer participates in Ohio. Proposition 78 is an 
improved version of Ohio’s program and will produce even 
larger discounts. 
Even opponents admit that Proposition 78 could result 
in 40% discounts for consumers. Because it is adapted 
from a program already in operation, Proposition 78 won’t 
be subject to lengthy court challenges. Unlike Prop. 79, 
Proposition 78 doesn’t need federal government approval. 
Prop. 78 can take effect immediately, helping millions of 
seniors and low income, uninsured Californians get relief 
from high prescription drug costs. 
The comparison to the Golden Bear program is 
misleading. That program was fl awed, couldn’t be 
implemented under federal rules to give Californians the 
largest discounts possible, and was abandoned by the state. 
Proposition 78 was written to FIX that problem. 
This year, the Schwarzenegger administration, working 
with leading Democrats, came together in the Legislature to 
support the Cal Rx program contained in Proposition 78. 
Had some legislators not succumbed to pressure from 
special interest groups and defeated Cal Rx in the Legislature, 
Californians would already be getting drug discounts. 
Opponents falsely claim Proposition 78 can be abolished 
by drug companies. ONLY THE STATE can end the program 
if, for example, federal law changes and a new program 
becomes available that is better for Californians. 
Proposition 78 is supported by dozens of groups 
representing seniors, taxpayers, small businesses, consumers, 
health care advocates, and patient groups. It offers millions 
of Californians real help, right now on prescription drug 
prices. Vote YES on Proposition 78. 
TOM MURPHY, Chair 
California Arthritis Foundation Council 
RUSTY HAMMER, President 
Los Angeles Area Chamber of Commerce 
JAMES S. GRISOLIA, M.D., Senior Vice President 
Epilepsy Foundation of San Diego County 
Rebuttal to Argument Against Proposition 78
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(k) Except for judicial decrees, the provisions of this article are 
the exclusive means of adjusting the boundary lines of the districts 
specifi ed herein. 
Section 2.  (a) Each member of the Senate, Assembly, Congress, 
and the Board of Equalization shall be elected from a single-member 
district. Districts of each type shall be numbered consecutively 
commencing at the northern boundary of the State and ending at the 
southern boundary. 
(b) The population of all districts of a particular type shall be 
as nearly equal as practicable. For congressional districts, the 
maximum population deviation between districts shall not exceed 
federal constitutional standards. For state legislative and Board of 
Equalization districts, the maximum population deviation between 
districts of the same type shall not exceed one percent or any stricter 
standard required by federal law. 
(c) Districts shall comply with any additional requirements of 
the United States Constitution and any applicable federal statute, 
including the federal Voting Rights Act. 
(d) Each Board of Equalization district shall be comprised of 10 
adjacent Senate districts and each Senate district shall be comprised of 
two adjacent Assembly districts. 
(e) Every district shall be contiguous. 
(f) District boundaries shall conform to the geographic boundaries 
of a county, city, or city and county to the greatest extent practicable. 
In this regard, a redistricting plan shall comply with these criteria in 
the following order of importance: (1) create the most whole counties 
possible, (2) create the fewest county fragments possible, (3) create 
the most whole cities possible, and (4) create the fewest city fragments 
possible, except as necessary to comply with the requirements of the 
preceding subdivisions of this section. 
(g) Every district shall be as compact as practicable except to the 
extent necessary to comply with the requirements of the preceding 
subdivisions of this section. With regard to compactness, to the extent 
practicable a contiguous area of population shall not be bypassed to 
incorporate an area of population more distant. 
(h) No census block shall be fragmented unless required to satisfy 
the requirements of the United States Constitution. 
(i) No consideration shall be given as to the potential effects on 
incumbents or political parties. No data regarding the residence of an 
incumbent or of any other candidate or the party affi liation or voting 
history of electors may be used in the preparation of plans, except as 
required by federal law. 
Section 3. Any action or proceeding alleging that a plan adopted 
by the Special Masters does not conform with the requirements of 
this article must be fi led within 45 days of the fi ling of the plan with 
the Secretary of State or such action or proceeding is forever barred. 
Judicial review of the conformity of any plan with the requirements of 
this article may be pursuant to a petition for extraordinary relief. If 
any court fi nds a plan to be in violation of this article, it may order 
that a new plan be adopted by a panel of Special Masters pursuant to 
this article. A court may order any remedy necessary to effectuate 
this article. 
In the year following the year in which the national census is taken 
under the direction of Congress at the beginning of each decade, the 
Legislature shall adjust the boundary lines of the Senatorial, Assembly, 
Congressional, and Board of Equalization districts in conformance 
with the following standards:
(a) Each member of the Senate, Assembly, Congress, and the Board 
of Equalization shall be elected from a single/member district.
(b) The population of all districts of a particular type shall be 
reasonably equal.
(c) Every district shall be contiguous.
(d) Districts of each type shall be numbered consecutively 
commencing at the northern boundary of the State and ending at the 
southern boundary.
(e) The geographical integrity of any city, county, or city and 
county, or of any geographical region shall be respected to the extent 
possible without violating the requirements of any other subdivision of 
this section.
SECTION 3.  Severability 
If any provision of this measure or the application thereof to any 
person or circumstance is held invalid, including, but not limited to, 
subdivision (b) of Section 1 of Article XXI, that invalidity shall not 
affect other provisions or applications which can reasonably be given 
effect in the absence of the invalid provision or application. 
SECTION 4.  Confl icting Ballot Measures 
(a) In the event that this measure and another measure or measures 
relating to the redistricting of Senatorial, Assembly, Congressional, 
or Board of Equalization districts is approved by a majority of voters 
at the same election, and this measure receives a greater number 
of affi rmative votes than any other such measure or measures, this 
measure shall control in its entirety and said other measure or measures 
shall be rendered void and without any legal effect. If this measure is 
approved but does not receive a greater number of affi rmative votes 
than said other measure or measures, this measure shall take effect to 
the extent permitted by law. 
(b) If this measure is approved by voters but superseded by law by 
any other confl icting ballot measure approved by the voters at the same 
election, and the confl icting ballot measure is later held invalid, this 
measure shall be self-executing and given full force of law. 
PROPOSITION 78
This initiative measure is submitted to the people in accordance with 
the provisions of Article II, Section 8, of the California Constitution.
This initiative measure adds sections to the Health and Safety Code; 
therefore, new provisions proposed to be added are printed in italic type 
to indicate that they are new.
PROPOSED LAW
SECTION 1.  FINDINGS AND DECLARATION OF PURPOSE
The people of the State of California do hereby fi nd and declare that: 
(a) Prescription drugs are an integral part to managing acute and 
chronic illness improving quality of life; and 
(b) Prescription drugs are a convenient, cost-effective alternative to 
more costly medical interventions; and 
(c) Increasing the affordability and access of prescription medicines 
will signifi cantly improve health care quality and lower overall health 
care costs. 
SEC. 2.  CALIFORNIA STATE PHARMACY ASSISTANCE 
PROGRAM (CAL RX)
Division 112 (commencing with Section 130600) is added to the 
Health and Safety Code, to read: 
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DIVISION 112.  CALIFORNIA STATE PHARMACY ASSISTANCE 
PROGRAM (CAL RX) 
CHAPTER 1.  GENERAL PROVISIONS 
130600.  This division shall be known, and may be cited, as the 
California State Pharmacy Assistance Program or Cal Rx. 
130601.  For the purposes of this division, the following defi nitions 
shall apply: 
(a) “Benchmark price” means the price for an individual drug or 
aggregate price for a group of drugs offered by a manufacturer equal to 
the lowest commercial price for the individual drug or group of drugs. 
(b) “Cal Rx” means the California State Pharmacy Assistance 
Program. 
(c) “Department” means the State Department of Health Services. 
(d) “Fund” means the California State Pharmacy Assistance 
Program Fund. 
(e) “Inpatient” means a person who has been admitted to a hospital 
for observation, diagnosis, or treatment and who is expected to remain 
overnight or longer. 
(f) (1) “Lowest commercial price” means the lowest purchase price 
for an individual drug, including all discounts, rebates, or free goods, 
available to any wholesale or retail commercial class of trade in California. 
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(2) Lowest commercial price excludes purchases by government 
entities, purchases pursuant to Section 340B of the federal Public 
Health Services Act (42 U.S.C. Sec. 256b), or nominal prices as defi ned 
in federal Medicaid drug rebate agreements. 
(3) A purchase price provided to an acute care hospital or acute 
care hospital pharmacy may be excluded if the prescription drug is used 
exclusively for an inpatient of the hospital. 
(4) Wholesale or retail commercial class of trade includes 
distributors, retail pharmacies, pharmacy benefi t managers, health 
maintenance organizations, or any entities that directly or indirectly sell 
prescription drugs to consumers through licensed retail pharmacies, 
physician offi ces, or clinics. 
(g) “Manufacturer” means a drug manufacturer as defi ned in 
Section 4033 of the Business and Professions Code. 
(h) “Manufacturer’s rebate” means the rebate for an individual 
drug or aggregate rebate for a group of drugs necessary to make the 
price for the drug ingredients equal to or less than the applicable 
benchmark price. 
(i) “Prescription drug” means any drug that bears the legend 
“Caution: federal law prohibits dispensing without prescription,” 
“Rx only,” or words of similar import. 
(j) “Private discount drug program” means a prescription drug 
discount card or manufacturer patient assistance program that provides 
discounted or free drugs to eligible individuals. For the purposes of this 
division, a private discount drug program is not considered insurance 
or a third-party payer program. 
(k) “Recipient” means a resident that has completed an application 
and has been determined eligible for Cal Rx. 
(l) “Resident” means a California resident pursuant to Section 17014 
of the Revenue and Taxation Code. 
(m) “Third-party vendor” means a public or private entity with 
whom the department contracts pursuant to subdivision (b) of Section 
130602, which may include a pharmacy benefi t administration or 
pharmacy benefi t management company. 
130602.  (a) There is hereby established the California State 
Pharmacy Assistance Program or Cal Rx. 
(b) The department shall provide oversight of Cal Rx. To implement 
and administer Cal Rx, the department may contract with a third-
party vendor or utilize existing health care service provider enrollment 
and payment mechanisms, including the Medi-Cal program’s fi scal 
intermediary. 
(c) Any resident may enroll in Cal Rx if determined eligible pursuant 
to Section 130605. 
CHAPTER 2.  ELIGIBILITY AND APPLICATION PROCESS 
130605.  (a) To be eligible for Cal Rx, an individual shall meet all of 
the following requirements at the time of application and reapplication 
for the program: 
(1) Be a resident. 
(2) Have family income, as reported pursuant to Section 130606, 
that does not exceed 300 percent of the federal poverty guidelines, as 
revised annually by the United States Department of Health and Human 
Services in accordance with Section 673(2) of the Omnibus Budget 
Reconciliation Act of 1981 (42 U.S.C. Sec. 9902), as amended. 
(3) Not have outpatient prescription drug coverage paid for in whole 
or in part by any of the following: 
(A) A third-party payer. 
(B) The Medi-Cal program. 
(C) The children’s health insurance program. 
(D) The disability medical assistance program. 
(E) Another health plan or pharmacy assistance program that uses 
state or federal funds to pay part or all of the cost of the individual’s 
outpatient prescription drugs. Notwithstanding any other provision of 
this division to the contrary, an individual enrolled in Medicare may 
participate in this program, to the extent allowed by federal law, for 
prescription drugs not covered by Medicare. 
(4) Not have had outpatient prescription drug coverage specifi ed in 
paragraph (3) during any of the three months preceding the month in 
which the application or reapplication for Cal Rx is made, unless any of 
the following applies: 
(A) The third-party payer that paid all or part of the coverage fi led 
for bankruptcy under the federal bankruptcy laws. 
(B) The individual is no longer eligible for coverage provided 
through a retirement plan subject to protection under the Employee 
Retirement Income Security Act of 1974 (29 U.S.C. Sec. 1001), 
as amended. 
(C) The individual is no longer eligible for the Medi-Cal program, 
children’s health insurance program, or disability medical assistance 
program. 
(b) Application and an annual reapplication for Cal Rx shall be 
made pursuant to subdivision (d) of Section 130606. An applicant, or a 
guardian or custodian of an applicant, may apply or reapply on behalf 
of the applicant and the applicant’s spouse and children. 
130606.  (a) The department or third-party vendor shall develop an 
application and reapplication form for the determination of a resident’s 
eligibility for Cal Rx. 
(b) The application, at a minimum, shall do all of the following: 
(1) Specify the information that an applicant or the applicant’s 
representative must include in the application. 
(2) Require that the applicant, or the applicant’s guardian or 
custodian, attest that the information provided in the application 
is accurate to the best knowledge and belief of the applicant or the 
applicant’s guardian or custodian. 
(3) Include a statement printed in bold letters informing the 
applicant that knowingly making a false statement is punishable under 
penalty of perjury. 
(4) Specify that the application and annual reapplication fee due 
upon submission of the applicable form is fi fteen dollars ($15). 
(c) In assessing the income requirement for Cal Rx eligibility, 
the department shall use the income information reported on the 
application and not require additional documentation. 
(d) Application and annual reapplication may be made at any 
pharmacy, physician offi ce, or clinic participating in Cal Rx, through 
a Web site or call center staffed by trained operators approved by the 
department, or through the third-party vendor. A pharmacy, physician 
offi ce, clinic, or third-party vendor completing the application shall 
keep the application fee as reimbursement for its processing costs. If it 
is determined that the applicant is already enrolled in Cal Rx, the fee 
shall be returned to the applicant and the applicant shall be informed of 
his or her current status as a recipient. 
(e) The department or third-party vendor shall utilize a secure 
electronic application process that can be used by a pharmacy, 
physician offi ce, or clinic, by a Web site, by a call center staffed 
by trained operators, or through the third-party vendor to enroll 
applicants in Cal Rx. 
(f) During normal hours, the department or third-party vendor shall 
make a determination of eligibility within four hours of receipt by Cal 
Rx of a completed application. The department or third-party vendor 
shall mail the recipient an identifi cation card no later than four days 
after eligibility has been determined. 
(g) For applications submitted through a pharmacy, the department 
or third-party vendor may issue a recipient identifi cation number for 
eligible applicants to the pharmacy for immediate access to Cal Rx. 
130607.  (a) The department or third-party vendor shall attempt to 
execute agreements with private discount drug programs to provide a 
single point of entry for eligibility determination and claims processing 
for drugs available in those private discount drug programs. 
(b) (1) Private discount drug programs may require an applicant 
to provide additional information, beyond that required by Cal Rx, to 
determine the applicant’s eligibility for discount drug programs. 
(2) An applicant shall not be, under any circumstances, required 
to participate in, or to disclose information that would determine the 
applicant’s eligibility to participate in, private discount drug programs 
in order to participate in Cal Rx. 
(3) Notwithstanding paragraph (2), an applicant may voluntarily 
disclose or provide information that may be necessary to determine 
eligibility for participation in a private drug discount program. 
(c) For those drugs available pursuant to subdivision (a), the 
department or third-party vendor shall develop a system that provides 
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a recipient with the best prescription drug discounts that are available 
to them through Cal Rx or through private discount drug programs. 
(d) The recipient identifi cation card issued pursuant to subdivision (g) 
of Section 130606 shall serve as a single point of entry for drugs available 
pursuant to subdivision (a) and shall meet all legal requirements for a 
uniform prescription drug card pursuant to Section 1363.03. 
CHAPTER 3.  ADMINISTRATION AND SCOPE 
130615.  (a) To the extent that funds are available, the department 
shall conduct outreach programs to inform residents about Cal Rx and 
private drug discount programs available through the single point of 
entry as specifi ed in subdivisions (a) and (d) of Section 130607. No 
outreach material shall contain the name or likeness of a drug. The name 
of the organization sponsoring the material pursuant to subdivision (b) 
may appear on the material once and in a font no larger than 10 point. 
(b) The department may accept on behalf of the state any gift, 
bequest, or donation of outreach services or materials to inform 
residents about Cal Rx. Neither Section 11005 of the Government Code, 
nor any other law requiring approval by a state offi cer of a gift, bequest, 
or donation shall apply to these gifts, bequests, or donations. For 
purposes of this section, outreach services may include, but shall not be 
limited to, coordinating and implementing outreach efforts and plans. 
Outreach materials may include, but shall not be limited to, brochures, 
pamphlets, fl iers, posters, advertisements, and other promotional items. 
(c) An advertisement provided as a gift, bequest, or donation 
pursuant to this section shall be exempt from Article 5 (commencing 
with Section 11080) of Chapter 1 of Part 1 of Division 3 of Title 2 of the 
Government Code. 
130616.  (a) Any pharmacy licensed pursuant to Article 7 
(commencing with Section 4110) of Chapter 9 of Division 2 of the 
Business and Professions Code may participate in Cal Rx. 
(b) Any manufacturer, as defi ned in subdivision (g) of Section 
130601, may participate in Cal Rx. 
130617.  (a) This division shall apply only to prescription drugs 
dispensed to noninpatient recipients. 
(b) The amount a recipient pays for a drug within Cal Rx shall be 
equal to the pharmacy contract rate pursuant to subdivision (c), plus 
a dispensing fee that shall be negotiated as part of the rate pursuant to 
subdivision (c), less the applicable manufacturer’s rebate. 
(c) The department or third-party vendor may contract with 
participating pharmacies for a rate other than the pharmacist’s usual 
and customary rate. However, the department must approve the 
contracted rate of a third-party vendor. 
(d) The department or third-party vendor shall provide a claims 
processing system that complies with all of the following requirements: 
(1) Charges a price that meets the requirements of subdivision (b). 
(2) Provides the pharmacy with the dollar amount of the discount to 
be returned to the pharmacy. 
(3) Provides a single point of entry for access to private discount 
drug programs pursuant to Section 130607. 
(4) Provides drug utilization review warnings to pharmacies 
consistent with the drug utilization review standards outlined in Section 
1927 of the federal Social Security Act (42 U.S.C. Sec. 1396r–8(g)). 
(e) The department or third-party vendor shall pay a participating 
pharmacy the discount provided to recipients pursuant to subdivision 
(b) by a date that is not later than two weeks after the claim is received. 
(f) The department or third-party vendor shall develop a program to 
prevent the occurrence of fraud in Cal Rx. 
(g) The department or third-party vendor shall develop a mechanism 
for recipients to report problems or complaints regarding Cal Rx. 
130618.  (a) In order to secure the discount required pursuant to 
subdivisions (b) and (c) of Section 130617, the department or third-
party vendor shall attempt to negotiate drug rebate agreements for 
Cal Rx with drug manufacturers. 
(b) Each drug rebate agreement shall do all of the following: 
(1) Specify which of the manufacturer’s drugs are included in the 
agreement. 
(2) Permit the department to remove a drug from the agreement in 
the event of a dispute over the drug’s utilization. 
(3) Require the manufacturer to make a rebate payment to the 
department for each drug specifi ed under paragraph (1) dispensed to 
a recipient. 
(4) Require the rebate payment for a drug to be equal to the amount 
determined by multiplying the applicable per unit rebate by the number 
of units dispensed. 
(5) Defi ne a unit, for purposes of the agreement, in compliance 
with the standards set by the National Council of Prescription Drug 
Programs. 
(6) Require the manufacturer to make the rebate payments to the 
department on at least a quarterly basis. 
(7) Require the manufacturer to provide, upon the request of the 
department, documentation to validate that the per unit rebate provided 
complies with paragraph (4). 
(8) Permit a manufacturer to audit claims for the drugs the 
manufacturer provides under Cal Rx. Claims information provided to 
manufacturers shall comply with all federal and state privacy laws that 
protect a recipient’s health information. 
(c) To obtain the most favorable discounts, the department may limit 
the number of drugs available within Cal Rx. 
(d) The entire amount of the drug rebates negotiated pursuant to this 
section shall go to reducing the cost to Cal Rx recipients of purchasing 
drugs. The Legislature shall annually appropriate an amount to cover 
the state’s share of the discount provided by this section. 
(e) The department or third-party vendor may collect prospective 
rebates from manufacturers for payment to pharmacies. The amount 
of the prospective rebate shall be contained in drug rebate agreements 
executed pursuant to this section. 
(f) Drug rebate contracts negotiated by the third-party vendor 
shall be subject to review by the department. The department may 
cancel a contract that it fi nds not in the best interests of the state or 
Cal Rx recipients. 
(g) The third-party vendor may directly collect rebates from 
manufacturers in order to facilitate the payment to pharmacies 
pursuant to subdivision (e) of Section 130617. The department shall 
develop a system to prevent diversion of funds collected by the third-
party vendor. 
130619.  (a) The department or third-party vendor shall generate a 
monthly report that, at a minimum, provides all of the following: 
(1) Drug utilization information. 
(2) Amounts paid to pharmacies. 
(3) Amounts of rebates collected from manufacturers. 
(4) A summary of the problems or complaints reported regarding 
Cal Rx. 
(b) Information provided in paragraphs (1), (2), and (3) of 
subdivision (a) shall be at the national drug code level. 
130620.  (a) The department or third-party vendor shall deposit all 
payments received pursuant to Section 130618 into the California State 
Pharmacy Assistance Program Fund, which is hereby established in the 
State Treasury. 
(b) Notwithstanding Section 13340 of the Government Code, moneys 
in the fund are hereby appropriated to the department without regard 
to fi scal years for the purpose of providing payment to participating 
pharmacies pursuant to Section 130617 and for defraying the costs of 
administering Cal Rx. Notwithstanding any other provision of law, no 
money in the fund is available for expenditure for any other purpose or for 
loaning or transferring to any other fund, including the General Fund. 
130621.  The department may hire any staff needed for the 
implementation and oversight of Cal Rx. 
130622.  The department shall seek and obtain confi rmation from 
the federal Centers for Medicare and Medicaid Services that Cal Rx 
complies with the requirements for a state pharmaceutical assistance 
program pursuant to Section 1927 of the federal Social Security Act 
(42 U.S.C. Sec. 1396r–8) and that discounts provided under the 
program are exempt from Medicaid best price requirements. 
130623.  (a) Contracts and change orders entered into pursuant 
to this division and any project or systems development notice shall be 
exempt from all of the following: 
(1) The competitive bidding requirements of State Administrative 
Manual Management Memo 03-10. 
(2) Part 2 (commencing with Section 10100) of Division 2 of the 
Public Contract Code. 
(3) Article 4 (commencing with Section 19130) of Chapter 5 of 
Part 2 of Division 5 of Title 2 of the Government Code. 
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(b) Change orders entered into pursuant to this division shall not 
require a contract amendment. 
130624.  The department may terminate Cal Rx if the department 
makes any one of the following determinations: 
(a) That there are insuffi cient discounts to participants to make 
Cal Rx viable.
(b) That there are an insuffi cient number of applicants for Cal Rx. 
(c) That the department is unable to fi nd a responsible third-party 
vendor to administer Cal Rx. 
130625.  Notwithstanding Chapter 3.5 (commencing with Section 
11340) of Part 1 of Division 3 of Title 2 of the Government Code, the 
director may implement this division in whole or in part, by means of 
a provider bulletin or other similar instructions, without taking 
regulatory action. 
SEC. 3.  GENERAL PROVISIONS 
(a) Confl icting Measures: 
(1) This measure is intended to be comprehensive. It is the intent 
of the people that in the event that this measure and another initiative 
measure or measures relating to the same subject shall appear on the 
same statewide election ballot, the provisions of the other measure or 
measures shall be deemed to be in confl ict with this measure. In the 
event that this measure shall receive a greater number of affi rmative 
votes, the provisions of this measure shall prevail in their entirety, and 
all provisions of the other measure or measures shall be null and void. 
(2) If this measure is approved by voters but superseded by law by 
any other confl icting ballot measure approved by the voters at the same 
election, and the confl icting ballot measure is later held invalid, this 
measure shall be self-executing and given full force of law. 
(b) Severability: The provisions of this chapter are severable. If any 
provision of this chapter or its application is held invalid, that invalidity 
shall not affect other provisions or applications that can be given effect 
without the invalid provision or application. 
(c) Amendment: The provisions of this act may be amended by 
a statute that is passed by a vote of two-thirds of the membership 
of each house of the Legislature and signed by the Governor. All 
amendments to this act shall be to further the act and shall be 
consistent with its purposes. 
PROPOSITION 79
This initiative measure is submitted to the people in accordance with 
the provisions of Article II, Section 8, of the California Constitution.
This initiative measure adds sections to the Health and Safety Code; 
therefore, new provisions proposed to be added are printed in italic type 
to indicate that they are new.
PROPOSED LAW
CHEAPER PRESCRIPTION DRUGS FOR CALIFORNIA ACT 
(CAL RX PLUS) 
SECTION 1.  Division 112 (commencing with Section 130500) is 
added to the Health and Safety Code, to read: 
DIVISION 112.  CHEAPER PRESCRIPTION DRUGS 
FOR CALIFORNIA ACT (CAL RX PLUS) 
CHAPTER 1.  GENERAL PROVISIONS
130500.  This division shall be known, and may be cited, as the 
Cheaper Prescription Drugs for California Program or Cal Rx Plus. 
130501.  The Cheaper Prescription Drugs for California Program, 
or Cal Rx Plus, is established to reduce prescription drug prices and 
to improve the quality of health care for residents of the state. The 
program is administered by the State Department of Health Services 
to use manufacturer rebates and pharmacy discounts to reduce 
prescription drug prices for Californians. 
130502.  The people of California fi nd that affordability is critical 
in providing access to prescription drugs for California residents. This 
program is enacted by the people to enable the state to take steps to make 
prescription drugs more affordable for qualifi ed California residents, 
thereby increasing the overall health of California residents, promoting 
healthy communities, and protecting the public health and welfare. It is 
not the intention of the state to discourage employers from offering or 
paying for prescription drug benefi ts for their employees or to replace 
employer-sponsored prescription drug benefi t plans that provide benefi ts 
comparable to those made available to qualifi ed California residents 
under this program. 
130503.  Cal Rx Plus shall be available to Californians facing high 
prescription drug costs to provide lower prescription drug prices. To 
the extent permitted by federal law, Cal Rx Plus shall also be available 
to small businesses and other entities, as defi ned, that provide health 
coverage for Californians. 
130504.  For purposes of this division, the following defi nitions apply: 
(a) “Department” means the State Department of Health Services. 
(b) “Fund” means the Cal Rx Plus Program Fund. 
(c) “Program” means the Cheaper Prescription Drugs for 
California Program or Cal Rx Plus. 
(d) (1) “Qualifi ed Californian” means a resident of California 
whose total unreimbursed medical expenses equal 5 percent or more of 
family income. 
(2) “Qualifi ed Californian” also means an individual enrolled in 
Medicare who may participate in this program, to the extent allowed by 
federal law, for prescription drugs not covered by Medicare. 
(3) “Qualifi ed Californian” also means a resident of California who 
has a family income equal to or less than 400 percent of the federal 
poverty guidelines and who shall not have outpatient prescription drug 
coverage paid for in whole or in part by the Medi-Cal program or the 
Healthy Families Program. 
(4) For purposes of this subdivision, the cost of drugs provided 
under this division is considered an expense incurred by the family for 
eligibility determination purposes. 
(e) “Prescription drug” means any drug that bears the legend 
“Caution: federal law prohibits dispensing without prescription,” 
“Rx only,” or words of similar import. 
CHAPTER 2.  PRESCRIPTION DRUG DISCOUNTS 
130510.  (a) The amount a Cal Rx Plus participant pays for a drug 
through the program shall be equal to the participating provider’s 
usual and customary charge or the pharmacy contract rate pursuant to 
subdivision (c), less a program discount for the specifi c drug or an average 
discount for a group of drugs or all drugs covered by the program. 
(b) In determining program discounts on individual drugs, the 
department shall take into account the rebates provided by the drug’s 
manufacturer and the state’s share of the discount. 
(c) The department may contract with participating pharmacies for 
a rate other than the pharmacies’ usual and customary rate. 
130511.  (a) The department shall negotiate drug rebate agreements 
with drug manufacturers to provide for discounts for prescription drugs 
purchased through Cal Rx Plus. 
(b) Consistent with federal law, the department shall seek to contract 
for drug rebates that result in a net price comparable to or lower than the 
Medicaid best price for drugs covered by the program. The department 
shall also seek to contract a net price comparable to or lower than the 
price for prescription drugs provided to the federal government. 
(c) To obtain the most favorable discounts, the department may limit 
the number of drugs available through the program. 
(d) No less than 95 percent of the drug rebates negotiated pursuant 
to this section shall be used to reduce the cost of drugs purchased by 
participants in the program. 
(e) (1) Any pharmacy licensed pursuant to Chapter 9 (commencing 
with Section 4000) of Division 2 of the Business and Professions Code 
may participate in the program. 
(2) Any drug manufacturer may participate in the program. 
130512.  (a) Subject to this section, the department may not 
enter into a new contract or extend an existing contract with a drug 
manufacturer for the Medi-Cal program if the drug manufacturer 
will not provide Cal Rx Plus a rate comparable to or lower than the 
Medicaid best price. This provision shall not apply to a drug for which 
there is no therapeutic equivalent. 
(b) To the extent permitted by federal law, the department may 
require prior authorization in the Medi-Cal program for any drug of a 
manufacturer that fails to agree to a price comparable to or lower than 
the Medi-Cal best price for prescription drugs purchased under 
this division. 
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